Ban & Monetization Policy
MyLiveRoom Rewards Program Rules & Eligibility
0 Commentaires
0 Parts
971 Vue
0 Aperçu
Rechercher
Découvrez de nouvelles personnes, créer de nouvelles connexions et faire de nouveaux amis
-
Connectez-vous pour aimer, partager et commenter!
-
Asia-Pacific Kirsten Rat Sarcoma (KRAS) Market: Targeted Oncology Therapies, Precision Medicine for Lung and Colorectal Cancer"Future of Executive Summary Asia-Pacific Kirsten Rat Sarcoma (KRAS) Market: Size and Share Dynamics Data Bridge Market Research analyses that the market is growing with a CAGR of 10.4% in the forecast period of 2021 to 2028 and is expected to reach 358.26 million by 2028. The Asia-Pacific Kirsten Rat Sarcoma (KRAS) report encompasses the key developments in the market with respect to...0 Commentaires 0 Parts 1KB Vue 0 Aperçu
-
Cancer Biomarkers Market Drivers: Shaping the Future of Precision OncologyThe landscape of modern medicine is being redefined by the rapid evolution of the Cancer Biomarkers Market Drivers, which are fundamentally changing how clinicians approach the diagnosis and treatment of malignancies. As of 2026, the shift from generalized chemotherapy to molecularly targeted therapies has turned biological indicators into the most valuable assets in the clinical toolkit. These...0 Commentaires 0 Parts 1KB Vue 0 Aperçu
-
Global BRAF Kinase Inhibitors Market to Reach USD 3.78 Billion by 2034 Amid Rising Precision Oncology AdoptionAccording to a new report from Intel Market Research, the global BRAF kinase inhibitors market was valued at USD 1.85 billion in 2025 and is projected to reach USD 3.78 billion by 2034, growing at a CAGR of 7.5% during the forecast period (2026–2034). This growth trajectory reflects the expanding applications of BRAF inhibitors in precision oncology and the increasing prevalence of...0 Commentaires 0 Parts 1KB Vue 0 Aperçu
-
Hemato Oncology Testing Market Size, Share, Precision Medicine Trends and Strategic Forecast 2032"Executive Summary Hemato Oncology Testing Market Size and Share: Global Industry Snapshot During the forecast period of 2025 to 2032 the market is likely to grow at a CAGR of 7.80% , primarily driven by the rising incidence of blood cancers Hemato Oncology Testing Market report offers the most appropriate solution for the business requirements in many ways. To be...0 Commentaires 0 Parts 2KB Vue 0 Aperçu
-
Hereditary Cancer Testing Market Size and Precision Oncology Trends 2033The growing emphasis on personalized medicine and proactive risk management is driving a significant expansion in genomic screening. The Hereditary Cancer Testing Market was valued at USD 7.04 billion in 2024 and is projected to reach USD 18.85 billion by 2032, growing at a CAGR of 20.87% during the forecast period of 2025 to 2032. This growth is fueled by the...0 Commentaires 0 Parts 510 Vue 0 Aperçu
-
Merkel Cell Carcinoma Treatment Market: Immune Checkpoint Inhibitor (ICI) Advancements, Combination Therapy Pipelines, and Precision Oncology Strategies"Latest Insights on Executive Summary Merkel Cell Carcinoma Treatment Market Share and Size Data Bridge Market Research analyses a growth rate in the merkel cell carcinoma treatment market in the forecast period 2022-2029. The expected CAGR of merkel cell carcinoma treatment market is tend to be around 3.87% in the mentioned forecast period. The market was valued at USD 3.24 billion in 2021,...0 Commentaires 0 Parts 1KB Vue 0 Aperçu
-
Precision Oncology Trends Accelerate Europe Circulating Tumor Cells (CTC) Liquid Biopsy Market"Global Demand Outlook for Executive Summary Europe Circulating Tumor Cells (CTC) Liquid Biopsy Market Size and Share Data Bridge Market Research analyses that the market is growing with a CAGR of 24.3% in the forecast period of 2022 to 2029 and is expected to reach USD 1,891.60 million by 2029 from USD 351.05 million in 2021. For a constantly increasing business growth and...0 Commentaires 0 Parts 1KB Vue 0 Aperçu
-
Salivary Gland Cancer Treatment Market: Targeted Therapy Pipeline, Precision Oncology Strategies"Executive Summary Salivary Gland Cancer Treatment Market Size and Share Analysis Report The global salivary gland cancer treatment market size was valued at USD 1.78 billion in 2024 and is expected to reach USD 3.27 billion by 2032, at a CAGR of 7.90% during the forecast period The global Salivary Gland Cancer Treatment Market research report has...0 Commentaires 0 Parts 2KB Vue 0 Aperçu
-
Therapeutic Radiopharmaceuticals Market Expands with Precision Oncology Advancements"In-Depth Study on Executive Summary Therapeutic Radiopharmaceuticals Market Size and Share CAGR Value Global therapeutic radiopharmaceuticals market size was valued at USD 4.95 billion in 2024 and is projected to reach USD 8.01 billion by 2032, with a CAGR of 6.2% during the forecast period of 2025 to 2032. As the high quality Therapeutic Radiopharmaceuticals Market survey report has...0 Commentaires 0 Parts 1KB Vue 0 Aperçu
-
Global Liquid Biopsy Market to Reach USD 28.84 Billion by 2033 Driven by Demand for Non-Invasive Cancer DiagnosticsThe global liquid biopsy market size was valued at USD 10.99 billion in 2024 and is projected to reach from USD 12.23 billion in 2025 to USD 28.84 billion by 2033, growing at a CAGR of 11.32% during the forecast period (2025-2033). The growth of the market is attributed to the increasing need for non-invasive procedures to support market growth, the advantages of...0 Commentaires 0 Parts 2KB Vue 0 Aperçu
-
How the Prostate Cancer Diagnostics Market Is Advancing with AI and Biomarker-Based Screening?Executive Summary Prostate Cancer Diagnostics Market: Growth Trends and Share Breakdown CAGR Value The global prostate cancer diagnostics market size was valued at USD 4.63 billion in 2024 and is expected to reach USD 10.31 billion by 2032, at a CAGR of 10.50% during the forecast period Prostate Cancer Diagnostics Market research report is a verified source of data and information that...0 Commentaires 0 Parts 6KB Vue 0 Aperçu
-
VEGF Inhibitors for Cancer Market Growing at 7.3% CAGR Amid Rising Targeted Oncology TherapiesAccording to a new report from Intel Market Research, the global VEGF Inhibitors for Cancer market was valued at USD 8.42 billion in 2025 and is projected to reach USD 15.67 billion by 2034, growing at a CAGR of 7.3% during the forecast period (2026–2034). This growth trajectory reflects the increasing adoption of targeted therapies in oncology and significant advancements in angiogenesis...0 Commentaires 0 Parts 2KB Vue 0 Aperçu
-
Why is hereditary cancer testing becoming more widely adopted worldwide?Future of Executive Summary Hereditary Cancer Testing Market: Size and Share Dynamics CAGR Value Data Bridge Market Research analyzes that the global hereditary cancer testing market is expected to reach the value of USD 13,085.04 million by 2029, at a CAGR of 12.9% during the forecast period. Hereditary Cancer Testing Market research report is a sure solution to get market insights...0 Commentaires 0 Parts 3KB Vue 0 Aperçu
-
Why Oncology Advancements Are Supporting the Europe Taxane MarketExecutive Summary Europe Taxane Market Size and Share Forecast CAGR Value Europe taxane market is expected to gain market growth in the forecast period of 2022 to 2029. Data Bridge Market Research analyses that the market is growing with a CAGR of 7.1% in the forecast period of 2022 to 2029. The Europe Taxane report also makes available CAGR value fluctuation during the forecast...0 Commentaires 0 Parts 3KB Vue 0 Aperçu
Plus de résultats
English
Arabic
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek
